Innovation and researching original drug molecules have played a key role in the Company’s strategy ever since it was founded in 1901. With more than 1,000 people in research and development, Gedeon Richter has become the most important pharmaceutical research centre in the region.
Our Company continues to focus on seeking new partners and establishing R&D cooperation agreements. We work together with academic institutions in the early stages of research and with industrial partners mainly on clinical developments.
It is vital for a company that thinks long-term to establish a presence in new areas that can serve as breakout points in the future, and biotechnology is just such an area in the pharmaceutical industry.